The present study evaluates the metabolic profile of blood plasma for distinguishing prostate cancer (PCa) patients with type 2 diabetes mellitus (T2DM), PCa and healthy controls using 1H-NMR spectroscopy. Our data showed significant lower concentration of glycine, glycerophosphocholine, choline and higher concentration of glucose in PCa patients with T2DM as compared to PCa patients and healthy control. Results provided an insight into the alterations in the metabolic pathways in T2DM-PCa and indicated that NMR spectroscopy may help in determining metabolic changes associated with PCa patients with T2DM and may help in diagnosis.
This abstract and the presentation materials are available to members only; a login is required.